Opinion statement
Multifocal motor neuropathy (MMN) is a unique disease mimicking motor neuron disease, but it is treatable with intravenous immunoglobulins. Anti-GM1 IgM antibody titers are not sensitive enough to predict the outcome. Electrodiagnosis is essential for the diagnosis of MMN. Conduction block has been suggested as the best diagnostic marker, but it is not found in all treatable cases. Activity-dependent conduction changes, as revealed by comparing conduction before and after maximal voluntary contraction of the muscle, are a convenient and promising tool. Treatment options include various immunosuppressants (including cyclophosphamide), but there has not been ample evidence in favor of any of these agents in randomized controlled trials. Intravenous immunoglobulins remain the mainstay for treating MMN.
Similar content being viewed by others
References and Recommended Reading
Roth G, Rohr J, Magistris MR, Ochsner F: Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol 1986, 25:416–423.
Parry GJ, Clarke S: Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988, 11:103–107.
Pestronk A, Cornblath DR, Ilyas AA, et al.: A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988, 24:73–78.
Kaji R, Shibasaki H, Kimura J: Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 1992, 42:506–509.
Kaji R, Oka N, Tsuji T, et al.: Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993, 33:152–158.
Kaji R, Bostock H, Kohara N, et al.: Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000, 123:1602–1611.
Slee M, Selvan A, Donaghy M: Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007, 69:1680–1687.
Donaghy M, Mills KR, Boniface SJ, et al.: Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994, 57:778–783.
Kiernan MC, Guglielmi JM, Kaji R, et al.: Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002, 125:664–675.
Kaji R: Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 2003, 27:285–296.
Kusunoki S, Mizutani K, Oka N, et al.: Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a. Muscle Nerve 2000, 23:702–706.
Nodera H, Bostock H, Izumi Y, et al.: Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test. Neurology 2006, 67:280–287.
Azulay JP, Blin O, Pouget J, et al.: Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 1994, 44:429–432.
Kubori T, Mezaki T, Kaji R, et al.: [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy] [Japanese]. No To Shinkei 1999, 51:127–135.
van Schaik IN, Bouche P, Illa I, et al.: European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol 2006, 13:802–808.
Umapathi T, Hughes R: Mycophenolate in treatmentresistant inflammatory neuropathies. Eur J Neurol 2002, 9:683–685.
Piepers S, Van den Berg-Vos R, Van der Pol WL, et al.: Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain 2007, 130:2004–2010.
Ruegg SJ, Fuhr P, Steck AJ: Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg. Neurology 2004, 63:2178–2179.
Gorson KC, Natarajan N, Ropper AH, Weinstein R: Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 2007, 35:66–69.
Brannagan TH 3rd, Alaedini A, Gladstone DE: High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve 2006, 34:246–250.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaji, R. Diagnosis and treatment of multifocal motor neuropathy. Curr Treat Options Neurol 10, 103–107 (2008). https://doi.org/10.1007/s11940-008-0012-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11940-008-0012-2